STERIS’ (TSE:STE – Free Report) – Investment analysts at Atb Cap Markets lifted their FY2025 earnings per share estimates for STERIS’ in a research report issued on Wednesday, March 12th. Atb Cap Markets analyst W. Syed now expects that the company will post earnings per share of $0.59 for the year, up from their prior estimate of $0.43. Atb Cap Markets currently has a “Strong-Buy” rating on the stock. Atb Cap Markets also issued estimates for STERIS’’s Q4 2025 earnings at ($0.11) EPS and Q4 2026 earnings at ($0.09) EPS.
Separately, Cormark raised STERIS’ to a “moderate buy” rating in a report on Monday, January 6th.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Read More
- Five stocks we like better than STERIS’
- Options Trading – Understanding Strike Price
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to Invest in Small Cap Stocks
- 3 Must-Own Stocks to Build Wealth This Decade
- The Significance of Brokerage Rankings in Stock Selection
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
